1. Allende, Maria L, Lee, Y Terry, Byrnes, Colleen, Tifft, Cynthia J, Proia, Richard L. 2023. Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis. In Journal of lipid research, 64, 100463. doi:10.1016/j.jlr.2023.100463. https://pubmed.ncbi.nlm.nih.gov/37871851/
2. Wu, Gan, Cao, Ben, Zhai, Haige, Yang, Xinyu, Wang, Jianguang. 2024. EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 3. In Annals of the rheumatic diseases, 83, 564-575. doi:10.1136/ard-2023-224852. https://pubmed.ncbi.nlm.nih.gov/38272667/
3. Yamaguchi, Kazunori, Koseki, Koichi, Shiozaki, Momo, Wada, Tadashi, Miyagi, Taeko. . Regulation of plasma-membrane-associated sialidase NEU3 gene by Sp1/Sp3 transcription factors. In The Biochemical journal, 430, 107-17. doi:10.1042/BJ20100350. https://pubmed.ncbi.nlm.nih.gov/20518744/
4. Mozzi, Alessandra, Forcella, Matilde, Riva, Alice, Fusi, Paola, Frattini, Milo. 2015. NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels. In Glycobiology, 25, 855-68. doi:10.1093/glycob/cwv026. https://pubmed.ncbi.nlm.nih.gov/25922362/
5. Miyata, Maiko, Kambe, Mariko, Tajima, Orie, Furukawa, Koichi, Furukawa, Keiko. 2011. Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides. In Cancer science, 102, 2139-49. doi:10.1111/j.1349-7006.2011.02086.x. https://pubmed.ncbi.nlm.nih.gov/21895867/